We are grateful for the extensive assistance provided by Ms. Tina Fung, MPH, Program Coordinator for The National Center for Reducing Asian American Cancer Health Disparities at UC Davis Comprehensive Cancer Center.
Adherence and retention in clinical trials: A community-based approach
Article first published online: 18 MAR 2014
© 2014 American Cancer Society
Supplement: Enhancing minority participation in clinical trials (EMPaCT): Laying the Groundwork for Improving Minority Clinical Trial Accrual
Volume 120, Issue Supplement S7, pages 1106–1112, April 1, 2014
How to Cite
Fouad, M. N., Johnson, R. E., Nagy, M. C., Person, S. D. and Partridge, E. E. (2014), Adherence and retention in clinical trials: A community-based approach. Cancer, 120: 1106–1112. doi: 10.1002/cncr.28572
The opinions or views expressed in this supplement are those of the authors and do not necessarily reflect the opinions or recommendations of the journal editors, the American Cancer Society, John Wiley & Sons, Inc., or the National Institute on Minority Health and Health Disparities.
- Issue published online: 18 MAR 2014
- Article first published online: 18 MAR 2014
- Manuscript Accepted: 15 AUG 2013
- Manuscript Revised: 12 AUG 2013
- Manuscript Received: 13 JUN 2013
- clinical trials;
- minority women;
- underserved women;
- African American women
The Community Health Advisor (CHA) model has been widely used to recruit rural and low-income, mostly African American women into clinical and behavioral research studies. However, little is known about its effectiveness in promoting retention and adherence of such women in clinical trials.
The Community-Based Retention Intervention Study evaluated the effectiveness of a community-based intervention strategy using the CHA model and the empowerment theory to improve the retention and adherence of minority and low-income women in clinical trials. The research strategy included the training and use of the volunteer CHAs as research partners. The target population included women participating in the University of Alabama at Birmingham clinical site of the Atypical Squamous Cells of Undetermined Significance–Low-Grade Squamous Intraepithelial Lesion (ASCUS-LSIL) Triage Study (ALTS), a multicenter, randomized clinical trial. Two communities in Jefferson County, Alabama, that were matched according to population demographics were identified and randomly assigned to either an intervention group or a control group. Thirty community volunteers were recruited to be CHAs and to implement the intervention with the ALTS trial participants. In total, 632 ALTS participants agreed to participate in the project, including 359 in the intervention group, which received CHA care, and 273 in the control group, which received standard care.
Adherence rates for scheduled clinic visits were significantly higher in the intervention group (80%) compared with the control group (65%; P < .0001).
The results indicate that volunteer CHAs can be trained to serve as research partners and can be effective in improving the retention and adherence of minority and low-income women in clinical trials. Cancer 2014;120(7 suppl):1106–12. © 2014 American Cancer Society.